Hilary Webber active positions
| Companies | Position | Start | End |
|---|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Chairman | - | - |
Career history of Hilary Webber
Former positions of Hilary Webber
| Companies | Position | Start | End |
|---|---|---|---|
| CANNASOUTH LIMITED | Director/Board Member | - | 01/01/2024 |
| Independent Dir/Board Member | - | 01/01/2024 |
Statistics
International
| New Zealand | 3 |
Operational
| Chairman | 1 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Stock Market
- Insiders
- Hilary Webber
- Experience
